Results 101 to 110 of about 40,022 (185)

Presumed macular toxicity of high-dose intravitreal ganciclovir

open access: yesTaiwan Journal of Ophthalmology
A 56-year-old male with bilateral cytomegalovirus retinitis was initiated on oral valganciclovir and intravitreal ganciclovir injection twice a week in first 2 weeks and once a week in subsequent weeks.
Shubhra Sweta   +5 more
doaj   +1 more source

Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients [PDF]

open access: yes, 2017
Objectives To determine whether valganciclovir 450 mg every 48 h for cytomegalovirus (CMV) prophylaxis provides appropriate ganciclovir exposure in solid organ transplant recipients during continuous renal replacement therapy (CRRT). Patients and methods
Aubert, J. D.   +8 more
core  

Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1

open access: yesMicrobiology Spectrum
Zoonotic infection by herpes B virus (BV) causes severe neurological disease, which in the absence of appropriate treatment can have a mortality rate of 80%.
Phu Hoang Anh Nguyen   +10 more
doaj   +1 more source

PREPARATION AND UNIT-DOSE DISPENSING OF GANCICLOVIR IN A UNIVERSITY HOSPITAL: INFECTION TREATMENT ASSOCIATED WITH PHARMACOECONOMICS

open access: yesBrazilian Journal of Infectious Diseases
Introduction: Medications represent a large portion of a hospital’s budget, and pharmacoeconomic studies are one way to reduce these costs. Medications such as ganciclovir can be prepared through compounding, with adjusted dosing, appropriate stability ...
Carlos Eduardo Prado   +12 more
doaj   +1 more source

Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report

open access: yesFrontiers in Medicine
Cytomegalovirus (CMV) infection is a common complication in patients undergoing hematopoietic stem cell transplantation (HSCT). Management of refractory CMV infections, especially in developing countries, can be challenging due to the limited ...
Alejandra Pando-Caciano   +4 more
doaj   +1 more source

Cytomegalovirus Retinitis: Decreased Risk of Bilaterality with Increased Use of Systemic Treatment [PDF]

open access: yes, 2017
Cytomegalovirus (CMV) retinitis may be treated systemically or intravitreally. We reviewed retrospectively patients with CMV retinitis, in order to determine whether systemic treatment was associated with less spread of CMV retinitis from one eye to the ...
Gabriel, Victor   +8 more
core  

Incidencia y gravedad de la enfermedad por citomegalovirus en pacientes trasplantados renales que han recibido tratamiento anticipado o profilaxis con valganciclovir oral [PDF]

open access: yes, 2012
Antecedentes: La infección por CMV es la más frecuente que sufren los receptores de trasplante de órgano sólido (TOS) en los primeros meses del trasplante.
Girado, Lluís   +4 more
core  

Cytomegalovirus oesophagitis in an HIV-infected patient

open access: yesCurrent Medicine Research and Practice, 2013
Gastrointestinal (GI) involvement of cytomegalovirus (CMV) infection is being recognized with increased frequency in patients with acquired immunodeficiency syndrome (AIDS).
Naveen Kishoria   +5 more
doaj  

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial. [PDF]

open access: yesEClinicalMedicine
Jacobs TG   +30 more
europepmc   +1 more source

Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. [PDF]

open access: yes, 1991
Dummer, JS   +8 more
core  

Home - About - Disclaimer - Privacy